Fabrice Bailly

Magnesium Chelating 2-Hydroxyisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-diones, as Inhibitors of HIV-1 Integrase and/or the HIV-1 Reverse Transcriptase Ribonuclease H Domain: Discovery of a Novel Selective Inhibitor of the Ribonuclease H Function

Muriel Billamboz, Fabrice Bailly, Cédric Lion et al. · Journal of Medicinal Chemistry · 2011 · 135 citations · Full text

Life Sciences, Chemistry, Medicinal Chemistry +14

Design, Synthesis, and Biological Evaluation of a Series of 2-Hydroxyisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-diones as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain

Muriel Billamboz, Fabrice Bailly, Maria Letizia Barreca et al. · Journal of Medicinal Chemistry · 2008 · 114 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +16

Reaction of Rosmarinic Acid with Nitrite Ions in Acidic Conditions: Discovery of Nitro- and Dinitrorosmarinic Acids as New Anti-HIV-1 Agents

Mélanie Dubois, Fabrice Bailly, Gladys Mbemba et al. · Journal of Medicinal Chemistry · 2008 · 80 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway

Floriane Gibault, Fabrice Bailly, Matthieu Corvaisier et al. · ChemMedChem · 2017 · 80 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity

Catherine W. Cai, Elena Lomonosova, Eileen A. Moran et al. · Antiviral Research · 2014 · 68 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11